Preliminary program, subject to change.
Thursday February 10th
09.00-09.10 Welcome address
Maria Gomez, coordinator – EXODIAB, Lund University
Session 1 Human islets in diabetes research, chair: Hindrik Mulder
09.10-09.40 Patrik Rorsman, Sahlgrenska akademien, Gothenburg, SE
“Metabolic regulation of glucagon secretion: from the clinic to the test tube and back”
09.40-10.20 Maike Sander, University of San Diego, California, US
“Insights into islet cell gene regulation from single-cell chromatin analyses”
10.20-10.50 Coffee, exhibitions
10.50-11.20 Al Powers, Vanderbilt University, Nashville, US
“Human islets as a research tool: proper and reproducible procedures in research”
Session 2: Cardiovascular complications in diabetes, chair: Isabel Goncalves
11.20-11.50 John Pernow, Karolinska institute, SE
“Diabetes and cardiovascular comlications: novel mediators and therapeutic targets”
11.50-12.50 Lunch
12.50-13.20 Andreas Edsfeldt, Lund University, SE
“Underlying vascular changes in type 2 diabetes”
Session 3: Hormone signalling and resistance, chair: Olga Göransson
13.20-13.50 Maria Pereira, Uppsala University, SE
Title tba
13.50-14.20 Charlotta Olofsson, Gothenburg University, SE
“Targeting secretion of high-molecular weeight adiponectin – a novel approach to treat Type 2-diabetes?”
14.20-14.50 Coffee, exhibitions
Session 4: Younger research session/abstract session, chair: Stefan Nobel
14.50-17.00 Younger researcher session, break-out sessions/rooms
Session 5: Keynote Lecture I, Chair: tba)
17.00-18.00 Bruce Spiegelmann, Harvard University, Boston, US
“Adipose Cells and Diabetes: Biochemical Pathways and Therapeutic Opportunities”
18.00-19.00 SRP internal meeting
Friday February 11th
Session 6: Diabetic kidney disease: novel concepts and therapies, chair: Julia Otten
09.00-09.30 Simon Satchell, University of Bristol, UK
“Endothelial glycocalyx in the pathogenesis of microvascular complications of diabetes”
09.30-10.00 Hiddo Lambers Heerspink, University medical Center Groningen, NL
“tba”
10.00-10.30 Coffee, exhibitions
10.30-11.00 Tba
Session 7: Non-pharmacological interventions in diabetes, chair: tba
11.00-11.30 Mike Lean, University of Glasgow, UK
“Remission of type 2 diabetes with the DiRECT diet programme: new insights into the disease-process and its management”
11.30-12.00 Julia Otten, Umeå University, SE
“Type 2 diabetes remission using diet replacement and eHealth”
12.00-12.30 Lunch, exhibitions
Session 8: How to classify diabetes precision medicine? Chair: Anita Öst
12.30-12.45 John Nolan, Trinity College, Dublin, Ireland,
“Introduction”
12.45-13.00 Simon J Griffin, University of Cambridge School of Clinical Medicine, UK
“tba”
13.00-13.15 Patricia Zaharia, German Diabetes Center, Düsseldorf, DE
“tba”
13.15-13.30 John Nolan, Simon J Griffin, Patricia Zaharia
“Subclassification of diabetes – Questions and answers”
13.30-14.00 Coffee, exhibitions
Session 9: Type 1 Diabetes – Innate and adaptive immunity, chair: tba
14.00-14.30 Malin Flodström Tullberg, Karolinska Institute, SE
“A viral trigger for type 1 diabetes”
14.30-15.00 Anna Blom, Lund university, SE
“Novel intracellular splice variants of complement inhibitor CD59 control insulin secretion”
Session 10: Keynote Lecture II, chair: Anita Öst
15.00-16.00 Jens Juul Holst, Copenhagen University, DK
“Glucagon: old player, novel role”
Competition result
Closing remarks – Organizing committee
4th Swedish Diabetes Summit 